Bovine viral diarrhoea virus (bvdv) diversity and vaccination. a review

Veterinary Quarterly

Volumn 29, Issue 2, 2007, Pages 60-67

  Kalaycioglu, A T ^a  

^a KAFKAS UNIVERSITY   (Turkey)

Author keywords

Antigenic diversity; Bovine viral diarrhoea virus infections; BVDV; BVDV diversity Cattle diseases; Genetic diversity; Intestinal diseases; Marker vaccines; Novel vaccines; Reproductiv disorders; Vaccination; Vaccines; Viral diseases

Indexed keywords

BACULOVIRUS VECTOR; BOVIDEC; BOVINE DIARRHEA VIRUS 1 VACCINE; BOVINE DIARRHEA VIRUS 1A VACCINE; BOVINE DIARRHEA VIRUS 2 VACCINE; BOVINE DIARRHEA VIRUS VACCINE; BREED BACK FP 10; GLYCOPROTEIN; GLYCOPROTEIN E; GLYCOPROTEIN E1; GLYCOPROTEIN E2; GLYCOPROTEIN GP 25; GLYCOPROTEIN GP 48; NUCLEOCAPSID PROTEIN; PROTEIN C; PSEUDORABIES VACCINE; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VACCINE; VIRUS VACCINE; VIRUS VECTOR;

AMINO ACID SUBSTITUTION; BOVINE DIARRHEA VIRUS; CATTLE DISEASE; CELLULAR IMMUNITY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEVER; GASTROINTESTINAL HEMORRHAGE; GENE THERAPY; GENETIC VARIABILITY; GENOTYPE; IMMUNE RESPONSE; INTRAUTERINE INFECTION; LEUKOPENIA; NONHUMAN; PHYLOGENY; RESPIRATORY TRACT DISEASE; REVIEW; RNA VIRUS INFECTION; T LYMPHOCYTE ACTIVATION; UNTRANSLATED REGION; VACCINATION; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUSES, BOVINE VIRAL; VACCINATION; VIRAL VACCINES;

BOS; BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 34447255206     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.2007.9695228     Document Type: Review

References (90)

1. Baker JC. The clinical manifestations of bovine viral diarrhea infection. Veterinary Clinics of North America: Food Animal Practice 1995: 11: 425–449.
2. Barkema HW, Bartels CJ, Van Wuijckhuise L, Hesselink JW, Holzhauer M, Weber MF, Franken P, Kock PA, Bruschke CJ and Zimme GM. Outbreak of bovine virus diarrhea on Dutch dairy farms induced by a bovine herpesvirus I marker vaccine contaminated with bovine virus diarrhea virus type 2. Tijdschrift voor Diergeneeskunde 2001: 126: 158–65.
3. Becher P, Orlich M, Kosmidou A, Konig M, Baroth M and Thiel HJ. Genetic diversity of pestiviruses: identification of novel groups and implications for classification. Virology 1999: 262: 64–71.
4. Becher P, Orlich M and Thiel HJ. RNA recombination between persisting pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal disease. Journal of Virology 2001: 75: 6256–6264.
5. Becher P. Avalos Ramirez R, Orlich M, Cedillo Rosales S, Konig M, Schweizer M, Stabler H, Schirrmeier H and Thiel HJ. Genetic and antigenic characterization of novel pestivirus genotypes: implications for classification. Virology 2003: 311: 96–104.
6. Beer M, Hehnen HR, Wolfmeyer A, Poll G, Kaaden OR and Wolf G. A new inactivated BVDV genotype I and II vaccine. An immunisation and challenge study with BVDV genotype I. Veterinary Microbiology 2000: 77: 195–208.
7. Bolin SR. The pathogenesis of mucosal disease. Veterinary Clinics of North America: Food Animal Practice 1995: 11: 489–500.
8. Bolin SR. Control of bovine viral diarrhoea infection by use of vaccination. Veterinary Clinics of North America: Food Animal Practice 1995: 11: 615–625.
9. Bolin SR and Ridpath JF. Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease. Archives of Virology 1996: 141: 1463–1477.
10. Brock KV. The persistence of bovine viral diarrhea virus. Biologicals 2003: 31: 133–135.
11. Brownlie J, Clarke MC, Hooper LB and Bell GD. Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Veterinary Record 1995: 137: 58–62.
12. Collett MS, Larson R, Gold C, Slrick CD, Anderson DK and Purchio AF. Molecular cloning and nucleotide sequence of the pestivirus bovine viral diarrhea virus. Virology 1988: 165: 191–195.
13. Couvreur B, Letellier C, Collard A. Quenon P, Dehan P, Hamers, C, Pastoret, PP and Kerkhofs, P. Genetic and antigenic variability in bovine viral diarrhea virus (BVDV) isolates from Belgium. Virus Research 2002: 85: 17–28.
14. Dean HJ and Leyh R. Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge. Vaccine 1999: 17: 1117–1124.
15. Dean HJ. Hunsaker BD, Bailey OD and Wasmoen T. Prevention of persistent infection in calves by vaccination of dams with noncytopathic type-1 modified-live bovine viral diarrhea virus prior to breeding. American Journal of Veterinary Research 2003: 64: 530–537.
16. Deregt D and Loewen KG. Bovine viral diarrhea virus: biotypes and disease. Canadian Veterinary Journal 1995 36: 371–377.
17. Deregt D, Bolin SR. Van den Hurk J, Ridpath JF and Gilbert SA. Mapping of a type 1-specific and type-common epitope on the E2 (gp53) protein of bovine viral diarrheoa with neutralization escape mutants. Virus Research 1998: 53: 81–90.
18. Deregt D. Van Rijn, P.A, Wiens TY and Van den Hurk J. Monoclonal antibodies to the E2 protein of a new genotype (type 2) of bovine viral diarrhea virus define three antigenic domains involved in neutralization. Virus Research 1998: 57: 171–181.
19. Donis RO. Molecular biology of bovine viral diarrhea virus and its interactions with the host. Veterinary Clinics of North America: Food Animal Practice 1995: U- 393–423.
20. Endsley JJ, Roth JA. Ridpath J and Neill J. Maternal antibody blocks humoral but not T-cell responses to BVDV. Biologicals 2003: 31: 123–125.
21. Fairbanks K. Sellnackel J and Chase CC. Evaluation of a modified live virus type-la bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge. Veterinary Therapeutics 2003: 4: 24–34.
22. Fairbanks KK, Rinehart CL. Ohnesorge WC, Loughin MM and Chase CC. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine. Journal of the American Veterinary Medical Association 2004: 225: 1898–1904.
23. Floegel-Niesmann G. Classical swine fever (CSF) marker vaccine. Trial 111. Evaluation of discriminatory ELlSAs. Veterinary Microbiology 2001: 83: 121–136.
24. Flores EF, Gil LH, Botton SA, Weiblen R, Ridpath JF, Kreutz LC, Pilati C. Driemeyer D, Moojen V and Wendelstein AC. Clinical, pathological and antigenic aspects of bovine viral diarrhea virus (BVDV) type2 isolates identified in Brazil. Veterinary Microbiology 2000: 77: 175–83.
25. Frey HR, Eicken K, Grummer B, Kenklies S, Oguzoglu TC and Moennig V. Foetal protection against bovine virus diarrhoea virus after two-step vaccination. Zoonoses and Public Health 2002: 49: 489–493.
26. Fritzemeier J, Haas L, Liebler E, Moennig V and Greiser-Wilke I. The development of early vs. late onset mucosal disease is a consequence of two different pathogenic mechanisms. Archives of Virology 1997: 142: 1335–1350.
27. Fulton RW, Ridpath JF, Saliki JT, Briggs RE, Confer AW, Burge LJ, Purdy CW, Loan RW, Duff GC and Payton ME. Bovine viral diarrhea virus (BVDV) lb: predominant BVDV subtype in calves with respiratory disease. Canadian Veterinary Journal 2002: 66: 181–190.
28. Fulton RW, Ridpath JF, Confer AW, Saliki JT, Burge U and Payton ME. Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes. Biologicals 2003: 31: 89–95.
29. Giangaspero M, Harasawa R, Zecconi A and Luzzago C. Genotypic characteristics of bovine viral diarrhea virus 2 strains isolated in northern Italy. Journal of Veterinary Medical Science 2001: 63: 1045–1049.
30. Giangaspero M and Harasawa R. Genetic variety of bovine viral diarrhea virus 2 strains isolated from sheep. Journal of veterinary Medical Science 2004: 66: 323–326.
31. Greiser-Wilke I, Grummer B and Moennig V. Bovine viral diarrhoea eradication and control programmes in Europe. Biologicals 2003: 31: 113–118.
32. Hamers C. Lecomte C, Kulcsar G, Lainbot M and Pastorct PP. Persistently infected cattle stabilise bovine viral diarrhea virus leading to herd specific strains. Veterinary Microbiology 1998: 61: 177–182.
33. Hamers C, Delian P, Couvrcur B, Lctcllier C. Kerkhofs P and Pastoret PP. Diversity among bovine pestiviruses. Veterinary Journal 2001: 161: 112–122.
34. Hamers C, Di valentine E, Lecomte C, Lambot M, Joris E, Genicot B and Pastoret PP. Virus neutralising antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves. Veterinary Journal 2002: 163: 61–67.
35. Harpin S, Hurley DJ, Mbikay M. Talbot B and Elazhary YJ. Vaccination of cattle widi a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2. Journal of General Virology 1999: 80: 3137–3144.
36. Heinz EX. Collett MS, Purcell RH. Gould. EA, Howard CR, Houghton, M E, Moormann R J M, Rice CM and Thiel HJ. Family Flaviviridae. In: Virus taxonomy. Seventh Report of the International Committee on Taxonomy of Viruses, 2000.
37. M.H.V. van Regenmortel, C.M. Fauget, D.H.L. Bishop, M.K. Carstens, S.M. Estes, S.M. Lemon, J. Maniloff, M.A. Mayo, D.J. McGeoch, C.R. Pringle and R.B. Wickner. Academic Press, San Diego, pp. 859–888.
38. Houe H. Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections. Veterinary Microbiology 1999: 64: 89–107.
39. Howard CJ, Clarke MC, Sopp P and Brownlie J. Systemic vaccination with inactivated bovine virus diarrhoea virus protects against respiratory challenge. Veterinary Microbiology 1994: 42: 171–179.
40. Kalaycioglu AT. Preliminary studies on die identification of vaccinal mimotopes of bovine viral diarrhoea virus using combinatorial peptide libraries. Doctoral thesis. Royal Veterinary College, London, 2006. p. 13.
41. Kovacs F, Magyar T, Rinehart C, Elbers K, Schlesinger K and Ohnesorge WC. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection. Veterinary Microbiology 2003: 96: 117–131.
42. Liang R, Van den Hurk JV, Babiuk LA and Van Duruen Littel-Van den Hurk S. Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle. Journal of General Virology 2006: 87: 2971–2982.
43. Lindberg AL. Bovine viral diarrhoea virus infections and its control. A review. Veterinary Quarterly 2003: 25: 1–16.
44. Lutticken D, Drexler C, Visser N and Kaden V. The relevance of CSF marker vaccines for field use. In: Proceedings of the OIE symposium of classical swine fever, Birmingham, UK, 1998, p. 17.
45. Mahony TJ. McCarthy FM, Gravel JL, Corney B, Young PL and Vilcck S. Genetic analysis of bovine viral diarrhoea viruses from Australia. Veterinary Microbiology 2005: 106: 1–6.
46. Makoschey B, Janssen, MG, Vrijenhoek MP, Korsten JH and Marel P. An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2. Vaccine 2001: 19: 3261–3268.
47. Meyers G and Thiel HJ. Molecular characterization of pestiviruses. Advances in Virus Research 1996- 47 53–118.
48. Mishra N, Pattnaik B, Vilcek S, Palil SS, Jain P, Swamy N, Bhatia S and Pradhan HK. Genetic typing of bovine viral diarrhoea isolates from India. Veterinary Microbiology 2004: 104: 207–212.
49. Moorman RJ. Bouma A, Kramps JA, Terpstra C and De Smith HJ. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Veterinary Microbiology 2000: 73: 209–219.
50. Nagai M, Ito T, Sugita S, Genno A, Takeuchi K, Ozawa T, Sakoda Y, Nishimori T, Takaniura K and Akashi H. Genomic and serological diversity of bovine viral diarrhea virus in Japan. Archives of Virology 2001: 146: 685–696.
51. Nettleton PF and Entrican G. Ruminant pestiviruses. The British Veterinary Journal 1995: 151: 615–642.
52. Nobiron I, Thompson I, Brownlie J and Collins ME. Cytokine adjuVancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice. Vaccine 2001: 19: 4226–4235.
53. Nobiron L, Thompson I, Brownlie J and Collins ME. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine 2003: 21: 2082–2092.
54. Patel JR, Shillcto RW, Williams J and Alexander DC. Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination. Archives of Virology 2002: 147: 2453–2463.
55. Patel JR, Didlick S and Quinton J. Variation in immuno-genicity of ruminant pestiviruses as determined by the neutralisation assay. Veterinary Journal 2005: 169: 468–72.
56. Paton DJ. Pestivirus diversity. Journal of Comparative Pathology 1995: 12: 215–236.
57. Pellerin C, Van den Hurk J, Lecomte J and Tijssen P. Identification a new group bovine viral diarhea virus strains associated with severe outbreaks and high mortalities. Virology 1994: 203: 260–269.
58. Potgieter LN. Immunology of bovine viral diarrhea virus. Veterinary Clinics of North America: Food Animal Practice 1995: 3: 501–520.
59. Pratelli A, Martella, V, Cirone F, Buonavoglia D, Elia G, Tcmpesta M, and Buonavoglia C. Genomic characterization of pestiviruses isolated from lambs and kids in southern Italy. Journal of Virological Methods 2001- 91 81–85.
60. Rice CM. Flaviviridae: the viruses and their replication. In: Field’s Virology, 3rd edition, 1996. Edited by
61. B.N. Fields, D.M. Knipe and P.M. Howley PM. Lippincott-Raven, Philedelphia, New York, pp 931–959.
62. Ridpath JF, Bolin SR and Dubovi EJ. Segregation of bovine viral diarrhea virus in to genotypes. Virology 1994: 205: 66–74.
63. Ridpath JF, Bolin SR. Delayed onset postvaccinal mucosal disease as a result of genetic recombination between genotype 1 and genotype 2 BVDV. Virology 1995: 212: 259–262.
64. Ridpath JF, Neill JD, Frey M and Landgraf JG. Phylogenetic, antigenic and clinical characterization of type 2 BVDV from North America. Veterinary Microbiology 2000: 77: 145–155.
65. Ridpath JF. BVDV genotypes and biotypes: practical implications for diagnosis and control. Biologicals 2003: 31: 127–131.
66. Ridpath JF. Neill JD. Endsley J and Roth JA. Effect of passive immunity on the development of a protective immune response against bovine viral diarrhea virus in calves. American Journal of Veterinary Research 2003: 64: 65–69.
67. Ridpath JF. Practical significance of heterogenecity among BVDV strains: Impact of biotype and genotype on U.S. control programs. Preventive Veterinary Medicine 2005: 72: 17–30.
68. Rosas CT, König P, Beer M, Dubovi EJ, Tischer BK and Osterrieder N. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins. Journal of General Virology 2007: 88: 748–757.
69. Sandvik T. Progress of control and prevention programs for bovine viral diarrhea virus in Europe. Veterinary Clinics of North America: Food Animal Practice 2004: 20: 151–169
70. Synge BA, Clark AM, Moar JA, Nicolson JT, Nettleton PF and Herring JA. The control of bovine viral diarrhoea virus in Shetland. Veterinary Microbiology 1999: 64: 169–183.
71. Tautz N, Meyers G and Thiel HJ. Pathogenesis of mucosal disease, a deadly disease of cattle caused by a pestivirus. Clinical Diagnostic Virology 1998: 10: 121–127.
72. Tautz N and Thiel HJ. Cytopathogenicity of pestiviruses. Cleavage of bovine viral diarrhea virus NS2-3 has to occur at a defined position to allow viral replication. Archives of Virology 2003: 148: 1405–1412.
73. Tajima M, Frey HR, Yamato O, Maede Y, Moennig V, Scholz H and Greiser-Wilke I. Prevalence of genotypes 1 and 2 of bovine viral diarrhea virus in Lower Saxony, Germany. Virus Research 2001: 76: 31–42.
74. Thiel HJ, Palegaman PGW and Moennig V. Pestiviruses. In: Field’s Virology, 3rd edition, 1996. Edited by
75. B.N. Fields, D.M. Knipe and P.M. Howley. Lippincott-Raven Publishers, Philadelphia, PA, pp. 1059–1073.
76. Tijssen P, Pellerin C, Lecomte J and Van Der Hurk J. Immunodominat E2 (gp53) sequences of highly virulent bovine viral diarrea group II viruses indicate a close resembelance to a subgroup of border disease viruses. Virology 1995: 217: 356–381.
77. Toplak I, Sandvik T, Barlic-Maganja D, Grom J and Paton DJ. Genetic typing of bovine viral diarrhea virus: most Slovenian isolates are of genotypes Id and If. Veterinary Microbiology 2004: 99: 175–185.
78. Van Oirschot JT, Kaashoek MJ, Rijsewijk FA and Stegeman JA. The use of marker vaccines in eradication of herpesviruses. Journal of Biotechnology 1996: 44: 75–81.
79. Van Oirschot JT. Diva vaccines that reduce virus transmission. Journal of Biotechnology 1999: 73: 195–205.
80. Van Oirschot JT, Bruschke CJ and Van Rijn PA: Vaccination of cattle against bovine viral diarrhoea. Veterinary Microbiology 1999: 64: 169–183.
81. Van Oirschot JT. Vaccinology of classical swine fever: from lab to field. Veterinary Microbiology 2003: 96: 367–384.
82. Van Oirschot JT. Emergency vaccination against classical swine fever. Developments in Biologicals 2003: 14: 259–267.
83. Van Rijn PA, Van Gennip HG, Uendertse CH, Bruschke CJ, Paton DJ, Moormann RJ and Van Oirschot JT. Subdivision of the pestivirus genus based on envelope glycoprotein E2. Virology 1997: 237: 337–348.
84. Vilcek S, Drew TW, McGoldrick A and Paton DJ. Genetic typing of bovine pestiviruses from England and Wales. Veterinary Microbiology 1999: 69: 227–237.
85. Vilcek S, Paton DJ, Durkovic B, Strojny L, Ibata G, Moussa A, Loitsch A, Rossmanith W, Vega S, Scicluna MT and Paifi V. Bovine viral diarrhoea virus genotype 1 can be separated into at least eleven genetic groups. Archives of Virology 2001: 146: 99–115.
86. Vilcek S, Durkovic B, Bobakova M, Sharp G. Paton DJ. Identification of bovine viral diarrhoea virus 2 in cattle in Slovakia. Veterinary Record 2002: 151: 150-152. 85.
87. Vilcek S, Greiser-Wilke I, Durkovic B, Obritzhauser W, Deutz A, Kofer J. Genetic diversity of recent bovine viral diarrhoea viruses from die southeast of Austria (Styria). Veterinary Microbiology 2003: 91: 285–291.
88. Vilcek S, Durkovic B, Kolesarova M, Greiser-Wilke I and Paton DJ. Genetic diversity of international bovine viral diarrhoea virus (BVDV) isolates: identification of a new BVDV-1 genetic group. Veterinary Research 2004 35: 609–615.
89. Wakeley PR, Turner JL, Ibata G, King DP, Sandvik T, Howard P and Drew TW. Characterisation of a type 2 bovine viral diarrhoea virus isolated from cattle in the UK. Veterinary Microbiology 2004: 102: 19–24.
90. Wolfmeyer A, Wolf G, Beer M, Strube W, Hehnen HR, Schmeer N and Kaaden OR. Genomic (5’UTR) and serological differences among German BVDV field isolates. Archives of Virology 1997: 142: 2049–2057.